Two Refractory Immune Thrombocytopenia Case Reports Showing Responsiveness to Fostamatinib

Immune thrombocytopenia (ITP) is immune-mediated platelet loss due to increased destruction and insufficient production. Treatment guidelines provide for first-line steroid-based therapies followed by thrombopoietin receptor agonists (TPO-RAs) and fostamatinib for chronic ITP. Fostamatinib demonstra...

Descripción completa

Detalles Bibliográficos
Autores principales: Innao, Vanessa, Calogero, Rosalba Donatella, Lo Presti, Fabrizio, Consoli, Ugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266907/
https://www.ncbi.nlm.nih.gov/pubmed/37323813
http://dx.doi.org/10.1155/2023/9953245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266907/
https://www.ncbi.nlm.nih.gov/pubmed/37323813
http://dx.doi.org/10.1155/2023/9953245

Ejemplares similares